Boston Trust Walden’s Synaptics SYNA Stock Holding History

Boston Trust Walden’s Portfolio SYNA Stock Details SYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-127,858	Closed	-$7.49M	–	352
2016 Q3	$7.49M	Sell	127,858 -739	-0.6%	-$40.6K	0.12%	192
2016 Q2	$6.91M	Sell	128,597 -2,128	-2%	-$146K	0.12%	198
2016 Q1	$10.4M	Sell	130,725 -134,428	-51%	-$10.2M	0.18%	173
2015 Q4	$21.3M	Sell	265,153 -102,630	-28%	-$8.71M	0.4%	87
2015 Q3	$30.3M	Sell	367,783 -13,543	-4%	-$1.02M	0.51%	64
2015 Q2	$33.1M	Buy	381,326 +1,889	+0.5%	+$172K	0.5%	74
2015 Q1	$30.9M	Buy	379,437 +126,312	+50%	+$9.54M	0.46%	91
2014 Q4	$17.4M	Buy	+253,125	New	+$16.9M	0.26%	154

Other funds holding SYNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State of Tennessee, Department of Treasury Nashville, Tennessee $29.8B AUM 29.48% 1-Year Est. Return

Boston Trust Walden's SYNA Position: Q4 2016 in Review

Boston Trust Walden sold out of Synaptics (SYNA) in Q4 2016, closing a stake of 127,858 shares — an estimated $7.49M sold.

Boston Trust Walden first reported a position in SYNA in Q4 2014 and held it in 8 quarters. The position peaked at $33.1M in Q2 2015. 253 funds tracked by Wall St. Rank hold SYNA as of Q4 2016.

Boston Trust Walden reported no remaining Synaptics position as of Q4 2016 after selling out during the quarter.
Boston Trust Walden sold 127,858 Synaptics shares in Q4 2016, an estimated $7.49M.
Boston Trust Walden first reported a position in Synaptics in Q4 2014 and held it in 8 quarters.
Boston Trust Walden's Synaptics position peaked at $33.1M in Q2 2015.
253 funds tracked by Wall St. Rank held Synaptics as of Q4 2016.

Based on Boston Trust Walden's 13F filing for Q4 2016, filed 1 Feb 2017.